Beta Drugs Ltd

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE351Y01019
  • NSEID: BETA
  • BSEID:
INR
2,504.00
130.3 (5.49%)
BSENSE

Aug 10, 03:30 PM

BSE+NSE Vol: 65018

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
125.55
93.96
87.27
103.39
100.21
93.76
88.29
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
125.55
93.96
87.27
103.39
100.21
93.76
88.29
Raw Material Cost
50.22
36.78
32.50
46.40
58.12
44.23
43.73
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
4.30
-0.69
3.54
2.90
-8.38
-0.26
-1.45
Employee Cost
20.40
18.68
16.82
16.48
16.02
15.18
13.91
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.00
0.00
0.00
-0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
23.26
21.50
17.42
16.30
14.74
17.28
13.63
Total Expenditure (Excl Depreciation)
98.18
76.28
70.28
82.08
80.50
76.42
69.83
Operating Profit (PBDIT) excl Other Income
27.37
17.68
16.99
21.31
19.71
17.34
18.46
Other Income
1.58
2.89
2.31
2.99
2.99
3.96
0.97
Operating Profit (PBDIT)
28.95
20.57
19.30
24.30
22.70
21.30
19.43
Interest
2.56
3.94
4.43
3.61
3.32
3.29
1.88
Exceptional Items
0.00
0.00
0.00
0.00
0.00
-2.22
-2.35
Gross Profit (PBDT)
26.39
16.63
14.87
20.69
19.38
15.79
15.20
Depreciation
4.35
4.80
4.39
4.24
3.73
3.57
3.24
Profit Before Tax
22.04
11.83
10.47
16.44
15.65
12.23
11.96
Tax
5.56
2.78
1.95
4.23
3.95
3.20
3.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
16.49
9.05
8.52
12.22
11.70
9.03
8.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
16.49
9.05
8.52
12.22
11.70
9.03
8.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.68
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
15.80
9.05
8.52
12.22
11.70
9.03
8.95
Equity Capital
11.09
10.14
10.14
10.09
10.09
10.09
9.61
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
14.25
8.93
8.4
12.11
11.6
8.95
8.87
Diluted Earnings per share
14.78
8.93
8.4
12.1
11.59
9.4
8.87
Operating Profit Margin (Excl OI)
21.8%
18.82%
19.47%
20.61%
19.67%
18.49%
20.91%
Gross Profit Margin
21.02%
17.7%
17.04%
20.01%
19.34%
16.84%
17.22%
PAT Margin
13.13%
9.63%
9.76%
11.82%
11.68%
9.63%
10.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is -15.82%

stock-summary

Standalone Net Profit

YoY Growth in quarter ended Jun 2026 is 40.19%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 35.42%

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is -42.65%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of Beta Drugs Ltd With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
125.55
851.40
-725.85
-85.25%
Other Operating Income
0.00
0.00
0.00
Total Operating income
125.55
851.40
-725.85
-85.25%
Raw Material Cost
50.22
120.36
-70.14
-58.28%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
4.30
14.55
-10.25
-70.45%
Employee Cost
20.40
406.21
-385.81
-94.98%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
23.26
147.33
-124.07
-84.21%
Total Expenditure (Excl Depreciation)
98.18
688.45
-590.27
-85.74%
Operating Profit (PBDIT) excl Other Income
27.37
162.95
-135.58
-83.20%
Other Income
1.58
16.42
-14.84
-90.38%
Operating Profit (PBDIT)
28.95
179.37
-150.42
-83.86%
Interest
2.56
43.30
-40.74
-94.09%
Exceptional Items
0.00
-1.15
1.15
100.00%
Gross Profit (PBDT)
26.39
134.92
-108.53
-80.44%
Depreciation
4.35
88.79
-84.44
-95.10%
Profit Before Tax
22.04
46.13
-24.09
-52.22%
Tax
5.56
24.39
-18.83
-77.20%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
16.49
21.74
-5.25
-24.15%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
16.49
21.74
-5.25
-24.15%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.68
0.00
0.68
Other related items
0.00
0.00
0.00
Consolidated Net Profit
15.80
21.74
-5.94
-27.32%
Equity Capital
11.09
31.36
-20.27
-64.64%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
14.25
1.39
12.86
925.18%
Diluted Earnings per share
14.78
1.39
13.39
963.31%
Operating Profit Margin (Excl OI)
21.80%
19.14%
0.00
2.66%
Gross Profit Margin
21.02%
15.85%
0.00
5.17%
PAT Margin
13.13%
2.55%
0.00
10.58%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 55.83 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 2.72% vs 8.09% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -15.82%

Quarterly - Standalone Net Profit
Standalone Net Profit 5.93 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 11.26% vs 64.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 40.19%

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.17 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 4.20% vs 49.01% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 35.42%

Quarterly - Interest
Interest 1.60 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -44.25% vs -9.46% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -42.65%

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.22%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025